Establishment and external validation of a prognostic model for predicting disease-free survival and risk stratification in breast cancer patients treated with neoadjuvant chemotherapy

about

Establishment and external validation of a prognostic model for predicting disease-free survival and risk stratification in breast cancer patients treated with neoadjuvant chemotherapy

Item

http://www.wikidata.org/entity/Q58806315

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Establishment and external val ...... with neoadjuvant chemotherapy

@en

Establishment and external val ...... with neoadjuvant chemotherapy

@nl

type

Item

label

Establishment and external val ...... with neoadjuvant chemotherapy

@en

Establishment and external val ...... with neoadjuvant chemotherapy

@nl

prefLabel

Establishment and external val ...... with neoadjuvant chemotherapy

@en

Establishment and external val ...... with neoadjuvant chemotherapy

@nl

P1476

Establishment and external val ...... with neoadjuvant chemotherapy

@en

P2093

Hongli Wang

http://www.w3.org/2001/XMLSchema#string

Jianguo Lai

http://www.w3.org/2001/XMLSchema#string

Jingwen Peng

http://www.w3.org/2001/XMLSchema#string

Peixian Chen

http://www.w3.org/2001/XMLSchema#string

Zihao Pan

http://www.w3.org/2001/XMLSchema#string

P2860

Nomograms in oncology: more than meets the eye

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria

The updated incidences and mortalities of major cancers in China, 2011

Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance)

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Clinicopathological characteristics of patients with HER2-positive breast cancer and the efficacy of trastuzumab in the People's Republic of China.

How to build and interpret a nomogram for cancer prognosis.

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.

P304

2347-2356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S171129

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30122984

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

6078091

http://www.w3.org/2001/XMLSchema#string